Trust Co. of Vermont Sells 185 Shares of Colgate-Palmolive (NYSE:CL)

Trust Co. of Vermont lowered its stake in shares of Colgate-Palmolive (NYSE:CL) by 0.6% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 29,448 shares of the company’s stock after selling 185 shares during the quarter. Trust Co. of Vermont’s holdings in Colgate-Palmolive were worth $2,858,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in CL. Union Savings Bank grew its position in Colgate-Palmolive by 76.6% during the fourth quarter. Union Savings Bank now owns 309 shares of the company’s stock valued at $25,000 after buying an additional 134 shares during the period. Avion Wealth lifted its holdings in Colgate-Palmolive by 78.1% during the fourth quarter. Avion Wealth now owns 399 shares of the company’s stock valued at $32,000 after purchasing an additional 175 shares during the last quarter. Atlantic Edge Private Wealth Management LLC purchased a new stake in Colgate-Palmolive during the fourth quarter valued at about $32,000. PSI Advisors LLC lifted its holdings in Colgate-Palmolive by 4,971.4% during the first quarter. PSI Advisors LLC now owns 355 shares of the company’s stock valued at $32,000 after purchasing an additional 348 shares during the last quarter. Finally, Core Wealth Advisors Inc. lifted its holdings in Colgate-Palmolive by 56.6% during the fourth quarter. Core Wealth Advisors Inc. now owns 404 shares of the company’s stock valued at $32,000 after purchasing an additional 146 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

NYSE CL traded up $1.68 on Tuesday, reaching $102.65. 5,267,206 shares of the company’s stock traded hands, compared to its average volume of 4,449,524. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $104.15. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.28. The stock has a 50-day simple moving average of $96.64 and a 200 day simple moving average of $91.05. The stock has a market cap of $84.22 billion, a PE ratio of 32.48, a P/E/G ratio of 3.54 and a beta of 0.39.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, July 26th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The business had revenue of $5.06 billion for the quarter, compared to analysts’ expectations of $5 billion. During the same period last year, the business earned $0.77 earnings per share. The business’s quarterly revenue was up 4.9% on a year-over-year basis. As a group, research analysts predict that Colgate-Palmolive will post 3.57 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Friday, July 19th will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.95%. The ex-dividend date is Friday, July 19th. Colgate-Palmolive’s dividend payout ratio is 63.29%.

Analyst Upgrades and Downgrades

CL has been the topic of several recent research reports. Evercore ISI upped their price objective on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the company an “outperform” rating in a report on Thursday, July 18th. TD Cowen increased their price target on shares of Colgate-Palmolive from $110.00 to $115.00 and gave the stock a “buy” rating in a report on Tuesday, July 30th. Stifel Nicolaus increased their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a report on Monday, July 22nd. Barclays increased their price target on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a report on Monday, July 29th. Finally, Morgan Stanley increased their price target on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a report on Monday, July 29th. Seven research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $101.11.

Insider Transactions at Colgate-Palmolive

In other news, insider Sally Massey sold 12,226 shares of the firm’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total value of $1,149,977.56. Following the transaction, the insider now owns 13,924 shares in the company, valued at $1,309,691.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.